Delivery Order SPE2DB20D2104-SPE2DB25FMHCG

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $11,372.01, is a Firm Fixed Price Delivery Order for the procurement of Eliquis 5 mg tablet 60 count. The contract has an ultimate completion date of January 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies,...
This federal contract award, valued at $91,560.21, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product used for various medical conditions. The contract has a period of performance through February 26, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
This federal contract award, valued at $6,173.04, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Eliquis 2.5 mg tablets in quantities of 60 per order. This is a firm fixed-price delivery order contract with an ultimate completion date of April 25, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order from the Defense Logistics Agency (DLA) for Eliquis 5 mg tablets. The contract, valued at $3,536.55, has an ultimate completion date of December 31, 2024 and is a firm fixed-price contract. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of a larger Indefinite Delivery...
This federal contract award, valued at $6,342.74, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a firm fixed price and an ultimate completion date of January 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $15,003.10, is for the delivery of Eliquis 5 mg tablets. It is a firm-fixed price delivery order contract with an ultimate completion date of December 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, valued at $8,149.92, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product used for various medical treatments. This is a firm fixed-price delivery order contract with an ultimate completion date of October 31, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,994.32, is a Delivery Order for the supply of Eliquis 5 mg tablets. It is a Firm Fixed Price contract with a period of performance through March 3, 2025. The contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen Drug Corp...
This federal contract award, valued at $4,914.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of Eliquis 5 mg tablets. The contract has an ultimate completion date of January 2, 2025 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying a wide range of medical products to federal government...
This federal contract award, valued at $13,987.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a Firm Fixed Price Delivery Order with a Period of Performance through November 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMHCG
    Delivery Order

This federal contract award, valued at $11,208.78, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order contract for the supply of Eliquis 5 mg tablets. It is a firm-fixed-price contract with an ultimate completion date of February 3, 2025. The contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the military and veteran healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 10:24 AM